Added to YB: 2025-12-30
Pitch date: 2025-12-29
PRPO [bullish]
Precipio, Inc.
+5.4%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.
Market Cap
$41.0M
Pitch Price
$22.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
-87.09
P/E
-28.67
EV/Sales
1.85
Sector
Health Care Providers and Services
Category
growth
Show full summary:
The portfolio I am taking into 2026 - Precipio, Inc.
PRPO: US blood cancer diagnostics w/ proprietary HemeScreen (14→2 day test time) & IV-Cell tech. 30%+ growth, near break-even, OPEX flat going forward. 15-20% topline growth, gross margins 45%→60% from mix shift. 2027: 11x PE, 1.2x EV/Sales. Est 40%+ annual returns next 4-5 years.
Read full article (1 min)